Tony Muchamuel

Author PubWeight™ 14.14^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	New IL-17 family members promote Th1 or Th2 responses in the lung: in vivo function of the novel cytokine IL-25.	J Immunol	2002	4.48
2	Nonproteasomal targets of the proteasome inhibitors bortezomib and carfilzomib: a link to clinical adverse events.	Clin Cancer Res	2011	2.56
3	Beneficial effect of novel proteasome inhibitors in murine lupus via dual inhibition of type I interferon and autoantibody-secreting cells.	Arthritis Rheum	2012	2.03
4	Design and synthesis of an orally bioavailable and selective peptide epoxyketone proteasome inhibitor (PR-047).	J Med Chem	2009	1.50
5	Inflammatory mediators in uveitis: differential induction of cytokines and chemokines in Th1- versus Th2-mediated ocular inflammation.	J Immunol	2002	1.33
6	Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis.	EMBO Mol Med	2014	0.95
7	Blockade of experimental atopic dermatitis via topical NF-kappaB decoy oligonucleotide.	J Invest Dermatol	2006	0.84
8	Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis.	Gut	2006	0.84